In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Manan Pareek
Manan Pareek
Manan Pareek Manan Pareek

Yale New Haven Hospital, New Haven (United States of America)

Specialities : Acute Coronary Syndromes , Acute Cardiac Care, Echocardiography, Hypertension, Risk Factors and Prevention

Dr. Manan Pareek is an MD, PhD, FAHA, FESC, currently working as a resident in internal medicine. He has co-supervised 3 masters theses and co-mentored 5 PhD-students. He has almost 13 years of teaching experience. Dr. Pareek has been a volunteer member of the Danish Society of Cardiology since 2014 where he has authored or co-authored 9 guidelines and been on the endorsement committees for two ESC guidelines (dual antiplatelet therapy and hypertension). He is also a member of the International Society of Cardiovascular Disease Epidemiology and Prevention, given his particular interest in these research areas. He has worked with hyperglycemia, insulin resistance, hypertension, biomarkers, and prediction of diabetes, cardiovascular disease, and mortality. Finally, Dr. Pareek serves as a peer reviewer for >30 journals and has reviewed abstracts for the American Heart Association and ESC in 2018 and 2019. He has authored or co-authored >120 publications (>75 peer-reviewed articles).

10 presentations from this speaker

YNHHS-COVID-19 - Cardiac Complications Registry

Event : ESC Congress 2020

  • Session : COVID and Cardiovascular Disease
  • Speaker : M Pareek (New Haven,US)

2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT

Event : ESC Congress 2019

  • Session : Hypertension: epidemiology, targets and comorbidities
  • Speaker : M Pareek (New Haven,US)

Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

Event : ESC Congress 2019

  • Session : Blood pressure targets in high risk patients: challenges and opportunities
  • Speaker : M Pareek (New Haven,US)

10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Event : ESC Congress 2018

  • Session : Outcome of coronary stenting up to 10 years
  • Speaker : M Pareek (New Haven,US)

Homeostatic model assessment derived insulin sensitivity only predicts incident myocardial infarction at long-term follow-up

Event : ESC Congress 2015

  • Session : Diabetes mellitus and cardiovascular disease
  • Speaker : M Pareek (New Haven,US)

Myeloid-related protein 8/14 is associated with increased platelet aggregation in patients with stable coronary artery disease

Event : ESC Congress 2014

  • Session : Antiplatelet therapy: Translational science
  • Speaker : M Pareek (New Haven,US)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are